Bioentrepreneurship education programmes in the United States

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Bioentrepreneurship education programmes in the United States
Go to paperABSTRACT: In this first paper of a new regular column, Arlen Meyers and Patrick…



Drug Patent Expirations for Feb 4, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ELOXATIN (oxaliplatin) Sanofi Aventis Us Patent number: 5,716,988 Expiration Date: Feb 7, 2016 For more information try a free trial



Drug Patent Expirations for Jan 28, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NUEDEXTA (dextromethorphan hydrobromide; quinidine sulfate) Avanir Pharms Patent number: RE 38,115 Expiration Date: Jan 26, 2016 UTIBRON (glycopyrrolate ; indacaterol maleate) Novartis Pharms Corp Patent number: 6,521,260 Expiration […]



Make in India — nowhere to go but up

Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.” I don’t doubt that India has growth potential, as it ranks 51st out of 54 nations that I compare in the Scientific American Worldview scorecard. The problem with Make in India’s encouraging proclamation is that […]



Drug Patent Expirations for Jan 14, 2016

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ZEMPLAR (paricalcitol) Abbvie Patent number: 5,597,815 Expiration Date: Jan 13, 2016 For more information try a free trial



DrugPatentWatch adds expired patents from 1985 to present

DrugPatentWatch now contains the most complete resources for pharmaceutical drug patents, expired and acrive, both in the United States and internationally. The most recent addition is the integration of drug patents dating back to the oldest records held by the US Food and Drug Administration. International equivalents for US patents are also available in more […]